• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Ahead of the Curve: Pharm Exec Profiles Five Recent Drug Launches

Feature
Article
Pharmaceutical ExecutivePharmaceutical Executive: September 2023
Volume 43
Issue 9

Pharm Exec’s latest selections of notable biopharma brand launches—some with novel preemptive approaches—highlight products that are paving uncharted paths across a diverse disease landscape.

Ahead of the curve

Follow the links below to read about each product:

Camzyos (Bristol Myers Squibb)

Enhertu (Daiichi Sankyo, AstraZeneca)

Rebyota (Ferring Pharmaceuticals)

Sunlenca (Gilead Sciences)

Tzield (Provention Bio, a Sanofi company)

Selections were made by Pharmaceutical Executive's editorial staff, with close input from Editorial Advisory Board members.

Download Issue PDF
Articles in this issue
Pharmaceutical Executive, September 2023 Issue (PDF)
Pharmaceutical Executive, September 2023 Issue (PDF)
Lisa LeCointe-Cephas
A New Era of Ethical Leadership
Ahead of the curve
Ahead of the Curve: Pharm Exec Profiles Five Recent Drug Launches
Enhertu
Survival Story: Enhertu
Rebyota
Gut Instinct: Rebyota
Tzield
Delaying Disease Onset: Tzield
Sunlenca
New Beginnings: Sunlenca
Camzyos
A Heartfelt Solution: Camzyos
Fortifying Defenses Pre-Patent Cliff
Fortifying Defenses Pre-Patent Cliff
Ollivier and Doyle
New Product Planning: The Function's Evolution in Pharma
Barbara Ryan
No Rate Relief in Sight for Biotech
Francis Pollaro
Will ‘X’ Mark the Spot for Pharma Advertisers?
Mike Hollan
Find the Solutions That People are Actually Asking for
Scott Braunstein
From Concept to Commercialization: Pushing the Envelope
Michael Hennessy Jr.
Eager to Educate
Recent Videos
Related Content
‘Selling a Vision’: Today’s Playbook for Startups

‘Selling a Vision’: Today’s Playbook for Startups

Jessica Meng
October 14th 2024
Article

The Big Pharma commercialization playbook doesn’t work for emerging life sciences companies bootstrapping their way up. Exploring three strategies that could be the ingredients of a winning formula for startups.

Gen-Z Influence on Pharma M&A

Gen-Z Influence on Pharma M&A

Miranda Schmalfuhs
March 14th 2024
Podcast

Ian Baer, Founder and Chief Soothsayer, Sooth, discusses how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract Gen-Z.

Stock.adobe.com

eHealth Survey Reveals Concerns Prior to Medicare Enrollment

Mike Hollan
October 14th 2024
Article

Respondents showed concern for cost increases and changes to benefits.

Transforming Cancer Care: Data, AI, and Patient-Centered Care

Transforming Cancer Care: Data, AI, and Patient-Centered Care

Francis Pollaro
July 20th 2023
Podcast

Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.

Dan Switzer

Thursday Night DTC Marketing: Q&A with Dan Switzer

Mike Hollan
October 3rd 2024
Article

Daiichi Sankyo’s head of US oncology business discusses the company’s first DTC television campaign for Enhertu.

Barbara Corcoran

Otsuka and Lundbeck Announce Barbara Corcoran Led Campaign to Raise Awareness of Alzheimer’s Dementia

Mike Hollan
September 30th 2024
Article

Corcoran is using her family’s personal story with the disease to promote awareness.